FINANCIALS

KRYS Krystal Biotech Inc 1711279

Income Statement
Revenue	krys-20240930	83,841,000
Net Income	krys-20240930	27,180,000
Profit Margin		32.42%

Balance Sheet
Current Assets	713,164,000
Assets	982,318,000
Current Liabilities	89,527,000
Liabilities	96,472,000
Equity	885,846,000
Shares Out	28,730,000

Cash Flow Statement
Operating Cash Flow	70,577,000
Investing Cash Flow	-79,661,000

Market Analysis
Market Cap	5,401,228,720
Price	148.39
BVPS	30.83
PB	4.81
EPS	3.65
PE	51.54
PS	16.11
FCF	-9,084,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view KRYS documents filed with the SEC.

KRYS Filings Clear

View A List of Tickers